English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer Journal article
Yao, Jingjing, Huang, Min, Shen, Qinghong, Ding, Ming, Yu, Shaofang, Guo, Yajuan, Lin, Yuefang, Zheng, Yaqiu, Chen, Wenbo, Yan, Wenxin, Liu, Zhongqiu, Wang, Dawei, Hu, Ming, Lu, Linlin. c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Yao, Jingjing;  Huang, Min;  Shen, Qinghong;  Ding, Ming;  Yu, Shaofang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.4/5.0 | Submit date：2023/01/30
Artesunate  C-myc  Gemcitabine Resistance  Pancreatic Cancer  Pd-l1  
Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation Journal article
Ding, Ming, Zhang, Shuwei, Guo, Yajuan, Yao, Jingjing, Shen, Qinghong, Huang, Min, Chen, Wenbo, Yu, Shaofang, Zheng, Yaqiu, Lin, Yuefang, Yan, Wenxin, Liu, Zhongqiu, Su, Tao, Lu, Linlin. Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation[J]. Molecular Cancer Research, 2022, 20(5), 810-822.
Authors:  Ding, Ming;  Zhang, Shuwei;  Guo, Yajuan;  Yao, Jingjing;  Shen, Qinghong; et al.
Favorite | TC[WOS]:13 TC[Scopus]:14  IF:4.1/4.8 | Submit date：2023/01/30
Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression Journal article
Chen, Wenbo, Zhang, Qisong, Ding, Ming, Yao, Jingjing, Guo, Yajuan, Yan, Wenxin, Yu, Shaofang, Shen, Qinghong, Huang, Min, Zheng, Yaqiu, Lin, Yuefang, Wang, Ying, Liu, Zhongqiu, Lu, Linlin. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression[J]. Chemico-Biological Interactions, 2022, 356.
Authors:  Chen, Wenbo;  Zhang, Qisong;  Ding, Ming;  Yao, Jingjing;  Guo, Yajuan; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.7/4.6 | Submit date：2023/01/30
Bas Homeostasis  Bsep  Epigenetics  Hcc  
Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology Journal article
Yao, Jingjing, Shen, Qinghong, Huang, Min, Ding, Ming, Guo, Yajuan, Chen, Wenbo, Lin, Yuefang, Zheng, Yaqiu, Yu, Shaofang, Yan, Wenxin, Su, Tao, Liu, Zhongqiu, Lu, Linlin. Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology[J]. Journal of Ethnopharmacology, 2022, 282.
Authors:  Yao, Jingjing;  Shen, Qinghong;  Huang, Min;  Ding, Ming;  Guo, Yajuan; et al.
Favorite | TC[WOS]:13 TC[Scopus]:12  IF:4.8/4.8 | Submit date：2023/01/30
Arnicolide d  Cancer  Centipeda Minima  Integrative Pharmacology  Src